Total oxidant status and bone resorption biomarkers in serum and gingival crevicular fluid of patients with periodontitis

Journal of Periodontology

Volumn 85, Issue 2, 2014, Pages 317-326

  Baltacioǧlu, Esra ^a   Kehribar, Malike Aslan ^a   Yuva, Pinar ^a   Alver, Ahmet ^a   Atagün, Ozlem Saracx ^a   Karabulut, Erdem ^b   Akalin, Ferda Alev ^b  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Aggressive periodontitis; Molecular biology; Oxidative stress; Periodontal disease

Indexed keywords

BIOLOGICAL MARKER; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; OXIDIZING AGENT; REACTIVE OXYGEN METABOLITE; TNFRSF11B PROTEIN, HUMAN; TNFSF11 PROTEIN, HUMAN;

ADULT; AGGRESSIVE PERIODONTITIS; ALVEOLAR BONE LOSS; BLOOD; CHEMISTRY; CHRONIC PERIODONTITIS; COMPARATIVE STUDY; FEMALE; GINGIVITIS; HUMAN; MALE; METABOLISM; OXIDATIVE STRESS; PERIODONTAL DISEASE; PERIODONTAL POCKET; PERIODONTICS; PHYSIOLOGY; TOOTH PLAQUE; YOUNG ADULT;

ADULT; AGGRESSIVE PERIODONTITIS; ALVEOLAR BONE LOSS; BIOLOGICAL MARKERS; CHRONIC PERIODONTITIS; DENTAL PLAQUE INDEX; FEMALE; GINGIVAL CREVICULAR FLUID; HUMANS; MALE; OSTEOPROTEGERIN; OXIDANTS; OXIDATIVE STRESS; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL INDEX; PERIODONTAL POCKET; RANK LIGAND; REACTIVE OXYGEN SPECIES; YOUNG ADULT;

EID: 84893867034     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2013.130012     Document Type: Article

References (52)

1. Bartold PM, Cantley MD, Haynes DR. Mechanisms and control of pathologic bone loss in periodontitis. Periodontol 2000 2010;53:55-69.
2. Patel SP, Pradeep AR, Chowdhry S. Crevicular fluid levels of plasma glutathione peroxidase (eGPx) in periodontal health and disease. Arch Oral Biol 2009;54:543-548.
3. Chapple IL, Matthews JB. The role of reactive oxygen and antioxidant species in periodontal tissue destruction. Periodontol 2000 2007;43:160-232.
4. D'Aiuto F, Nibali L, Parkar M, Patel K, Suvan J, Donos N. Oxidative stress, systemic inflammation, and severe periodontitis. J Dent Res 2010;89: 1241-1246.
5. Waddington RJ, Moseley R, Embery G. Reactive oxygen species: A potential role in the pathogenesis of periodontal diseases. Oral Dis 2000;6:138-151.
6. Akalin FA, Baltacioglu E, Alver A, Karabulut E. Lipid peroxidation levels and total oxidant status in serum, saliva and gingival crevicular fluid in patients with chronic periodontitis. J Clin Periodontol 2007;34:558-565.
7. Ekuni D, Firth JD, Nayer T, et al. Lipopolysaccha-ride-induced epithelial monoamine oxidase mediates alveolar bone loss in a rat chronic wound model. Am J Pathol 2009;175:1398-1409.
8. Singer RE, Moss K, Beck JD, Offenbacher S. Association of systemic oxidative stress with suppressed serum IgG to commensal oral biofilm and modulation by periodontal infection. Antioxid Redox Signal 2009;11:2973-2983.
9. Basu S, Michaëlsson K, Olofsson H, Johansson S, Melhus H. Association between oxidative stress and bone mineral density. Biochem Biophys Res Commun 2001;288:275-279.
10. Brock GR, Butterworth CJ, Matthews JB, Chapple IL. Local and systemic total antioxidant capacity in periodontitis and health. J Clin Periodontol 2004;31: 515-521.
11. Baltacioglu E, Akalin FA, Alver A, Balaban F, Unsal M, Karabulut E. Total antioxidant capacity and superoxide dismutase activity levels in serum and gingival crevicular fluid in post-menopausal women with chronic periodontitis. J Clin Periodontol 2006; 33:385-392.
12. Akalin FA, Baltacioglu E, Alver A, Karabulut E. Total antioxidant capacity and superoxide dismutase activity levels in serum and gingival crevicular fluid in pregnant women with chronic periodontitis. J Periodontol 2009;80:457-467.
13. Baek KH, Oh KW, Lee WY, et al. Association of oxidative stress with postmenopausal osteoporosis and the effects of hydrogen peroxide on osteoclast formation in human bone marrow cell cultures. Calcif Tissue Int 2010;87:226-235.
14. Takayanagi H. Inflammatory bone destruction and osteoimmunology. J Periodontal Res 2005;40: 287-293.
15. Cochran DL. Inflammation and bone loss in peri-odontal disease. J Periodontol 2008;79(Suppl. 8): 1569-1576.
16. Graves D. Cytokines that promote periodontal tissue destruction. J Periodontol 2008;79(Suppl. 8): 1585-1591.
17. Belibasakis GN, Bostanci N. The RANKL-OPG system in clinical periodontology. J Clin Periodontol 2012;39:239-248.
18. Mogi M, Otogoto J, Ota N, Togari A. Differential expression of RANKL and osteoprotegerin in gingival crevicular fluid of patients with periodontitis. J Dent Res 2004;83:166-169.
19. Vernal R, Chaparro A, Graumann R, Puente J, Valenzuela MA, Gamonal J. Levels of cytokine receptor activator of nuclear factor kappaB ligand in gingival crevicular fluid in untreated chronic peri-odontitis patients. J Periodontol 2004;75:1586-1591.
20. Lu HK, Chen YL, Chang HC, Li CL, Kuo MY. Identification of the osteoprotegerin/receptor activator of nuclear factor-kappa B ligand system in gingival crevicular fluid and tissue of patients with chronic periodontitis. J Periodontal Res 2006;41: 354-360.
21. Bostanci N, Ilgenli T, Emingil G, et al. Gingival crevicular fluid levels of RANKL and OPG in peri-odontal diseases: Implications of their relative ratio. J Clin Periodontol 2007;34:370-376.
22. Mogi M, Otogoto J. Expression of cathepsin-K in gingival crevicular fluid of patients with peri-odontitis. Arch Oral Biol 2007;52:894-898.
23. Sakellari D, Menti S, Konstantinidis A. Free soluble receptor activator of nuclear factor-kappab ligand in gingival crevicular fluid correlates with distinct pathogens in periodontitis patients. J Clin Periodon-tol 2008;35:938-943.
24. Kim HJ, Chang EJ, Kim HM, et al. Antioxidant a-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-a. Free Radic Biol Med 2006; 40:1483-1493.
25. Sul OJ, Kim JC, Kyung TW, et al. Gold nano-particles inhibited the receptor activator of nuclear factor-kb ligand (RANKL)-induced osteoclast formation by acting as an antioxidant. Biosci Biotechnol Biochem 2010;74:2209-2213.
26. Bai XC, Lu D, Bai J, et al. Oxidative stress inhibits osteoblastic differentiation of bone cells by ERK and NF-kappaB. Biochem Biophys Res Commun 2004; 314:197-207.
27. Galli C, Passeri G, Macaluso GM. FoxOs, Wnts and oxidative stress-induced bone loss: New players in the periodontitis arena? J Periodontal Res 2011;46: 397-406.
28. Ohnishi T, Bandow K, Kakimoto K, Machigashira M, Matsuyama T, Matsuguchi T. Oxidative stress causes alveolar bone loss in metabolic syndrome model mice with type 2 diabetes. J Periodontal Res 2009;44:43-51.
29. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6.
30. Page RC, Eke PI. Case definitions for use in population-based surveillance of periodontitis. J Periodontol 2007;78(Suppl. 7):1387-1399.
31. Löe H, Silness J. Periodontal disease in pregnancy. Prevalance and severity. Acta Odontol Scand 1963; 21:533-551.
32. Mühlemann HR, Son S. Gingival sulcus bleeding-A leading symptom in initial gingivitis. Helv Odontol Acta 1971;15:107-113.
33. Silness J, Löe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 1964;22:121-135.
34. Rüdin HJ, Overdiek HF, Rateitschak KH. Correlation between sulcus fluid rate and clinical and histological inflammation of the marginal gingiva. Helv Odontol Acta 1970;14:21-26.
35. Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005; 38:1103-1111.
36. Wei D, Zhang XL, Wang YZ, Yang CX, Chen G. Lipid peroxidation levels, total oxidant status and superoxide dismutase in serum, saliva and gingival crevicular fluid in chronic periodontitis patients before and after periodontal therapy. Aust Dent J 2010;55:70-78.
37. Esen C, Alkan BA, Kirnap M, Akgül O, Isikoglu S, Erel O. The effects of chronic periodontitis and rheumatoid arthritis on serum and gingival crevicular fluid total antioxidant/oxidant status and oxidative stress index. J Periodontol 2012;83:773-779.
38. Konopka T, Krol K, Kopec W, Gerber H. Total antioxidant status and 8-hydroxy-2'-deoxyguanosine levels in gingival and peripheral blood of periodontitis patients. Arch Immunol Ther Exp (Warsz) 2007;55:417-422.
39. Armitage GC, Cullinan MP. Comparison of the clinical features of chronic and aggressive periodontitis. Periodontol 2000 2010;53:12-27.
40. Mizuno N, Niitani M, Shiba H, et al. Proteome analysis of proteins related to aggressive periodontitis combined with neutrophil chemotaxis dysfunction. J Clin Periodontol 2011;38:310-317.
41. Kantarci A, Van Dyke TE. Resolution of inflammation in periodontitis. J Periodontol 2005;76(Suppl. 11):2168-2174.
42. Ryder MI. Comparison of neutrophil functions in aggressive and chronic periodontitis. Periodontol 2000 2010;53:124-137.
43. Ozcaka O, Nalbantsoy A, Kose T, Buduneli N. Plasma osteoprotegerin levels are decreased in smoker chronic periodontitis patients. Aust Dent J 2010;55:405-410.
44. Lappin DF, Eapen B, Robertson D, Young J, Hodge PJ. Markers of bone destruction and formation and periodontitis in type 1 diabetes mellitus. J Clin Periodontol 2009;36:634-641.
45. Jabbar S, Drury J, Fordham JN, Datta HK, Francis RM, Tuck SP. Osteoprotegerin, RANKL and bone turnover in postmenopausal osteoporosis. J Clin Pathol 2011;64:354-357.
46. Wagner D, Fahrleitner-Pammer A. Levels of osteoprotegerin (OPG) and receptor activator for nuclear factor kappa B ligand (RANKL) in serum: Are they of any help? Wien Med Wochenschr 2010;160: 452-457.
47. Bostanci N, Saygan B, Emingil G, Atilla G, Belibasakis GN. Effect of periodontal treatment on receptor activator of NF-kB ligand and osteoprotegerin levels and relative ratio in gingival crevicular fluid. J Clin Periodontol 2011;38:428-433.
48. Taubman MA, Kawai T, Han X. The new concept of periodontal disease pathogenesis requires new and novel therapeutic strategies. J Clin Periodontol 2007; 34:367-369.
49. Gümüs P, Buduneli E, Biyikoglu B, et al. Gingival crevicular fluid, serum levels of receptor activator of nuclear factor-kappa B ligand, osteoprotegerin, in-terleukin-17 in rheumatoid arthritis and osteoporosis patients with periodontal disease [published online ahead of print January 17, 2013]. J Periodontol. doi:10.1902/jop.2013.120595.
50. Lee NK, Choi YG, Baik JY, et al. A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation. Blood 2005;106:852-859.
51. Tobón-Arroyave SI, Isaza-Guzmán DM, Restrepo-Cadavid EM, Zapata-Molina SM, Mart́inez-Pabón MC. Association of salivary levels of the bone remodelling regulators sRANKL and OPG with periodontal clinical status. J Clin Periodontol 2012;39: 1132-1140.
52. Frodge BD, Ebersole JL, Kryscio RJ, Thomas MV, Miller CS. Bone remodeling biomarkers of periodontal disease in saliva. J Periodontol 2008;79:1913-1919.